These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24012446)

  • 1. [Erythropoiesis-stimulating agents in congestive heart failure patients].
    Robles Perez-Monteoliva NR; Macías Núñez JF; Herrera Pérez de Villar J
    Med Clin (Barc); 2014 Mar; 142(5):215-8. PubMed ID: 24012446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoiesis stimulating agents (ESAs) for congestive heart failure: the red and the black.
    Robles NR; Macias JF; Herrera J
    Eur J Intern Med; 2014 Feb; 25(2):193-6. PubMed ID: 24491240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents.
    Geisler BP
    Expert Opin Biol Ther; 2010 Aug; 10(8):1209-16. PubMed ID: 20557272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of erythropoiesis-stimulating agents in anaemic patients with chronic heart failure.
    Jin B; Luo X; Lin H; Li J; Shi H
    Eur J Heart Fail; 2010 Mar; 12(3):249-53. PubMed ID: 20031949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are erythropoiesis-stimulating agents beneficial for anemia in chronic heart failure patients?
    Araneda D; Rada G
    Medwave; 2016 Nov; 16(Suppl5):e6607. PubMed ID: 27922585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summaries of nursing care-related systematic reviews from the Cochrane library: erythropoiesis-stimulating agents for anemia in chronic heart failure patients.
    Barrett D
    J Cardiovasc Nurs; 2010; 25(5):381-2. PubMed ID: 20714234
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoiesis-stimulating agents in kidney and cardiac disease.
    Fluck R
    Br J Hosp Med (Lond); 2006 Oct; 67(10):533-7. PubMed ID: 17069130
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating anemia with erythropoiesis-stimulating agents: effects on quality of life.
    Moossavi S; Freedman BI
    Arch Intern Med; 2009 Jun; 169(12):1100-1. PubMed ID: 19546408
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: A meta-analysis of randomized clinical trials.
    Kang J; Park J; Lee JM; Park JJ; Choi DJ
    Int J Cardiol; 2016 Sep; 218():12-22. PubMed ID: 27209352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agents.
    Lawler PR; Filion KB; Eisenberg MJ
    J Card Fail; 2010 Aug; 16(8):649-58. PubMed ID: 20670844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition and treatment of anemia in the setting of heart failure due to systolic left ventricular dysfunction.
    Howlett JG
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):199-208. PubMed ID: 18248274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoiesis stimulating agents in heart failure patients with anemia: a meta-analysis.
    Tehrani F; Dhesi P; Daneshvar D; Phan A; Rafique A; Siegel RJ; Cercek B
    Cardiovasc Drugs Ther; 2009 Dec; 23(6):511-8. PubMed ID: 19862609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of anemia in heart failure patients].
    Santilli G; Tarantini L; Baio P; Senni M
    G Ital Cardiol (Rome); 2011 May; 12(5):319-26. PubMed ID: 21593950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoiesis-stimulating agents for the management of anemia of chronic kidney disease: past advancements and current innovations.
    Dutka P
    Nephrol Nurs J; 2012; 39(6):447-57. PubMed ID: 23469411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and heart failure: the end of a promise?
    Kleijn L; Westenbrink BD; van der Meer P
    Eur J Heart Fail; 2013 May; 15(5):479-81. PubMed ID: 23558218
    [No Abstract]   [Full Text] [Related]  

  • 16. Anemia and heart failure: Is there still a role for erythropoiesis-stimulating agents?
    Volpe M; Mastromariona V
    Turk Kardiyol Dern Ars; 2017 Apr; 45(3):217-218. PubMed ID: 28429688
    [No Abstract]   [Full Text] [Related]  

  • 17. Anemia: A Connection Between Heart Failure and Kidney Failure.
    Locatelli F; Del Vecchio L; Minutolo R; De Nicola L
    Cardiol Clin; 2021 Aug; 39(3):319-333. PubMed ID: 34247747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoiesis-stimulating agents and heart failure.
    Lipšic E; van der Meer P; van Veldhuisen DJ
    Cardiovasc Ther; 2011 Aug; 29(4):e52-9. PubMed ID: 20973926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of erythropoiesis-stimulating agents in patients with anemia of chronic kidney disease: overcoming the pharmacological and pharmacoeconomic limitations of existing therapies.
    Wish JB; Coyne DW
    Mayo Clin Proc; 2007 Nov; 82(11):1371-80. PubMed ID: 17976358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
    Ponikowski P; Anker SD; Szachniewicz J; Okonko D; Ledwidge M; Zymlinski R; Ryan E; Wasserman SM; Baker N; Rosser D; Rosen SD; Poole-Wilson PA; Banasiak W; Coats AJ; McDonald K
    J Am Coll Cardiol; 2007 Feb; 49(7):753-62. PubMed ID: 17306703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.